Latina women at risk of hereditary breast and ovarian cancer are less likely to be referred for genetic counseling and testing.
The findings of a new qualitative study underscore the need to develop multilevel implementation strategies to overcome barriers and leverage facilitators to improve access to genetic counseling and testing (GCT) for those at risk of hereditary breast and ovarian cancer (HBOC).
The results were published in the Journal of Genetic Counseling.
The study can also inform the development of implementation toolkits for community-based organizations (CBOs) to implement HBOC screening tools to advance health equity, authors wrote.
Variants in the BRCA1 and BRCA2 genes are most strongly associated with HBOC, though other variants in additional genes are also linked with a heightened risk of HBOC. Because of this, participation in GCT can yield critical information to inform risk management in women both with and without cancer.
The United States Preventive Services Task Force currently recommends primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with BRCA1/2 gene variants with a validated familial risk assessment tool. Those with a positive result should receive genetic counseling and may consider genetic testing, authors explained.
In the United States, CBOs provide health care to a large portion of the medically underserved, who are also more likely to belong to racially and ethnically diverse communities.
“Given the health disparities Latina women encounter in accessing GCT for hereditarycancer risk including lack of referrals, CBOs have the potential to serve as bridges between Latinas at risk for HBOC and GCT services by identifying potentially at-risk women through screening tools,” researchers said.
In the current study, investigators assessed focus groups at 2 academic centers that were partnered with 4 CBOs in the Washington, DC, metropolitan area and Virginia. These centers planned to implement a validated questionnaire for HBOC risk screening. Researchers then analyzed CBOs’ preferences for screening tools, along with barriers and facilitators anticipated for future implementation.
Data showed:
Participants had an average age of around 50 years, and just under half self-identified as Hispanic or Latino. All individuals included worked or volunteered at a CBO that served the Latino community. Participants included nurses, patient navigators, community health workers, health care providers, directors and administrators.
Because the study only included CBOs from the mid-Atlantic region, findings may not be generalizable to other regions, marking a limitation.
“Future studies should expand the number and type of CBOs engaged in research to further examine potential differences and properly tailor implementation strategies based on CBO characteristics,” authors added.
Overall, “community-based organizations are uniquely positioned to connect underserved diverse populations to genetic services due to the long lasting trust, shared culture and language, and commitment to the community” they wrote.
“Findings from this study can inform the development of a HBOC screening needs assessment and an implementation strategies toolkit that could be tailored for different types of CBOs,” researchers concluded.
Reference
Bowen A, Gómez-Trillos S, Curran G, et al. Advancing health equity: a qualitative study assessing barriers and facilitators of implementing hereditary breast and ovarian cancer risk screening tools in community-based organizations. J Genet Couns. Published online March 13, 2023. doi:10.1002/jgc4.1705
Specialty Pharmacists at the Forefront: Elevating Care for Rare Diseases
May 1st 2024In the US, a disease is considered rare when it affects fewer than 200,000 persons, or 1 in every 1500 individuals, with an estimated total of 25 to 30 million Americans overall living with a rare disease at any given time.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
BRCA-Like Classification May Be a Useful Biomarker for Olaparib Response in Ovarian Cancer
May 1st 2024Adding olaparib to maintenance therapy with bevacizumab was associated with significantly longer survival for patients with ovarian cancer whose tumors have a BRCA-like genomic profile, but not among those with non-BRCA-like tumors, a study found.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
The Federal Trade Commission (FTC) issued letters to 10 companies to warn them that certain drug patents were improperly listed; the US Department of Agriculture (USDA) will begin testing ground beef for bird flu particles; rural Americans are more likely to die early from 1 of the 5 leading causes of death than those who live in urban areas.
Read More